Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 3/20 | 0.42 |
| ▸ | LDHB | P07195 | 3/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | PSMG3 | Q9BT73 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.37 |
| ▸ | GLRB | P48167 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | FASN | P49327 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29434000 | 1.00 | LDHA (0.42) | LDHALDHBDPP4PSMG3CYP3A4 | |
| SCHEMBL8830267 | 0.92 | LDHA (0.48) | LDHALDHBDPP4PSMG3CYP3A4 | |
| SCHEMBL15958196 | 0.89 | LDHA (0.45) | LDHALDHBDPP4PSMG3CYP3A4 | |
| SCHEMBL28389101 | 0.89 | LDHA (0.45) | LDHALDHBDPP4PSMG3CYP3A4 | |
| SCHEMBL18677527 | 0.89 | LDHA (0.45) | LDHALDHBDPP4PSMG3CYP3A4 | |
| SCHEMBL18677490 | 0.86 | LDHA (0.48) | LDHALDHBDPP4PSMG3CYP3A4 | |
| SCHEMBL7577609 | 0.86 | LDHA (0.46) | LDHALDHBDPP4PSMG3CYP3A4 | |
| SCHEMBL10404342 | 0.86 | LDHA (0.52) | LDHALDHBDPP4PSMG3CYP3A4 | |
| SCHEMBL5590144 | 0.84 | LDHA (0.57) | LDHALDHBDPP4PSMG3CYP3A4 | |
| SCHEMBL4124451 | 0.83 | LDHA (0.50) | LDHALDHBDPP4PSMG3CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260140083-A1 | Regenerative Plant Sensor | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026099334-A1 | SELF-ELIMINATING CLEAVABLE LINKERS | Miltenyi Biotec B.V. & Co. KG (DE) | 2026-05-15 | — | — | WO | claimed |
| EP-4214303-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4721767-A1 | ANTI-B7-H3 ANTIBODY OR FRAGMENT THEREOF, AND ANTIBODY DRUG CONJUGATE TARGETING B7-H3 | Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| US-12553043-B2 | Methods and compositions for messenger RNA purification | TRANSLATE BIO, INC. (US) | 2026-02-17 | — | — | US | claimed |
| EP-4673748-A1 | OVARIAN CANCER RISK PREDICTION | AroCell AB (SE) | 2026-01-07 | — | — | EP | claimed |
| US-12508321-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-12-30 | — | — | US | claimed |
| EP-4666071-A2 | AFFINITY REAGENTS HAVING ARTIFICIAL POLYMER SCAFFOLDS | Nautilus Subsidiary, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4519402-B1 | 1-NORBORNAN-2-YLPROPAN-2-ONE AS A FRAGRANCE | SYMRISE AG (DE) | 2025-12-10 | — | — | EP | claimed |
| CN-109156873-A | A kind of essence highlighting tongue fur note style and features and the cigarette comprising the essence | 云南中烟工业有限责任公司 | 2019-01-08 | — | — | CN | claimed |
| CN-109156879-A | A kind of essence highlighting tongue fur note style and features and the cigarette comprising the essence | 云南中烟工业有限责任公司 | 2019-01-08 | — | — | CN | claimed |
| EP-2084254-B2 | FRAGRANCE COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2018-08-08 | — | — | EP | claimed |
| EP-2084254-B1 | FRAGRANCE COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2015-02-25 | — | — | EP | claimed |
| EP-2084255-B1 | FRAGRANCE COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2014-01-22 | — | — | EP | claimed |
| EP-2142631-B1 | METHODS FOR TREATING FABRIC IN A DRYER | DIAL CORP (US) | 2012-03-14 | — | — | EP | claimed |
| WO-2011147455-A1 | FLAVORING SUBSTANCE-INCLUDED COMPOUNDS | SYMRISE AG (DE) | 2011-12-01 | — | — | WO | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| EP-1056739-B1 | NOVEL CYCLIC PRO-PERFUMES HAVING MODIFIABLE FRAGRANCE RAW MATERIAL ALCOHOL RELEASE RATE | PROCTER & GAMBLE (US) | 2003-05-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12508321-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | CD4, CD2, B2M | LDHA 1650/4885LDHB 765/4885DPP4 2335/4885 |
| US-12553043-B2 | Methods and compositions for messenger RNA purification | RNGTT, RNMT, UPF1 | LDHA 4782/4885LDHB 4766/4885DPP4 2200/4885 |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | DCLRE1A, CCR3, CCR8 | LDHA 2263/4885LDHB 2092/4885DPP4 3223/4885 |
| US-20260140083-A1 | Regenerative Plant Sensor | SLIRP, SNRK, NCS1 | LDHA 2883/4885LDHB 3557/4885DPP4 3431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.